Thyroid News
Clinical Thyroidology – Highlighted Article

From Clinical Thyroidology:  Levothyroxine-Treated Women in Their Reproductive Years Should Have their Serum TSH Adjusted Before Conception to Prevent Hypothyroidism in the First Trimester Thyroid dysfunction is associated with adverse obstetric outcomes, but there is limited information on pregnancy outcomes in women on levothyroxine therapy at the time of conception…

Clinical Thyroidology for the Public – highlighted article

From Clinical Thyroidology for the Public: What are the best approaches for diagnosing the etiology of thyrotoxicosis following delivery?Approximately 5-10% of women will develop thyroid dysfunction during the first year after delivery of a baby. …

ATA receives Interactive Media Award (IMA) for Outstanding Achievement Award

We are happy to announce the ATA website, www.thyroid.org, has won the Interactive Media Award (IMA) for Outstanding Achievement Award in the category of Association. Read More….

New Hypothyroidism Treatment Guidelines from American Thyroid Association Published in Thyroid Journal

New Rochelle, NY, September 30, 2014—Levothyroxine (L-T4), long the standard of care for treating hypothyroidism, is effective in most patients, but some individuals do not regain optimal health on L-T4 monotherapy. New knowledge about thyroid physiology may help to explain these differences. An expert task force of the American Thyroid Association® on thyroid hormone replacement reviewed the latest studies on L-T4 therapy and on alternative treatments to determine whether a change to the current standard of care is appropriate, and they present their recommendations in the article “Guidelines for the Treatment of Hypothyroidism,” published in Thyroid, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers and the official journal of the American Thyroid Association® (ATA). The Guidelines are available free on the Thyroid website. Read More…